We completely underestimated the number of diabetics, who were using the diabetes drug called Actos, and then developed bladder cancer
(PRWEB) November 07, 2012
The US Drug Watchdog is now saying, "We completely underestimated the number of diabetics, who were using the diabetes drug called Actos, and then developed bladder cancer. We are now urging family members, friends, or loved ones of diabetics, who have been diagnosed with bladder cancer, to ask if they were using the diabetes drug called Actos. Unfortunately, the use of Actos for diabetes, and an elevated chance of bladder cancer could to be related." According to the AP, "The FDA has issued a warning that Actos may be linked to an increased risk of bladder cancer. Meanwhile, both Germany and France have suspended sales of Actos. The Actos suspension is effective July 11, 2011. Actos (pioglitazone), along with another diabetes drug made by Takeda Pharmaceutical, Competact, came under fire in Europe after a study revealed an increased risk for bladder cancer among diabetes patients who were taking the medication." The US Drug Watchdog says, "We now fear bladder cancer, and diabetics using the diabetes drug called Actos is a much bigger problem than we ever dreamed possible, and are encouraging Actos all users who now have bladder cancer to contact the Johnson Law Group at 1-800-624-8899." For more information about the Johnson Law Group please visit their web site at http://www.johnsonlawgroup.com/
The US Drug Watchdog says, "One of the biggest problems we have with respect to our drug initiative work, is the average US consumer never hears about a drug recall, or serious side effects related to a specific drug's use. We are attempting to change this very sad fact with aggressive initiatives focused on increasing public awareness, and hopefully suggesting possible help for victims." http://USDrugWatchdog.Com
Case number 11cv2406 BEN BGS in the Federal District Court San Diego, CA.